Skip to main content
. 2022 Sep 6;13:963638. doi: 10.3389/fphar.2022.963638

FIGURE 3.

FIGURE 3

Flow cytometry analysis. Relative to the control group, proportion of IL17+/RORγt+, CD8+/IFNγ+, and CD49b+/CD107a+ cells in the peripheral blood of mice in the CHMACS-treated group was significantly higher. **p < 0.01 vs. control; *p < 0.05 vs. control; n = 6; t-test.